Alerts & Changes
Alerts and Changes provide information about notices or changes to import conditions. You can keep informed with these notices by following individual import cases.
Filter Alerts & Changes
Showing 1 - 10 results of 56
Resumption of measures to manage the risk of Xylella in imported Cannabis nursery stock(Important)
Effective from 11 April 2025
The import conditions for Cannabis spp. nursery stock have been revised.
Effective immediately, imported Cannabis spp. plants must undergo post-entry quarantine (PEQ) testing in Australia to confirm that plants are free from Australia’s top priority p...
Related Cases:
Cannabis spp. as nursery stock
Expansion of the CBIS onto test kits not testing for disease agents(Important)
Effective from 11 April 2025
The department is expanding the onto multiple document-controlled commodity import pathways.
The department is adding test kits not testing for disease agents onto the CBIS. This change is scheduled to take effect on 1 May 2025. CBIS will manage the...
Related Cases:
Test kits
Expansion of the CBIS onto one of the purified antibodies import pathway(Important)
Effective from 11 April 2025
The department is expanding the onto multiple document-controlled pathways.
The department is adding purified antibodies raised against inorganic material or antigens from multicellular organisms onto the CBIS. This change is scheduled to take effec...
Related Cases:
Purified antibodies
Changes to the Dog semen case(Important)
Effective from 9 April 2025
The BICON Case for dog semen has been redesigned to assist users understand the import conditions which must be met to import dog semen into Australia. The model veterinary health certificate will also be updated on the department’s website, and a link...
Related Cases:
Frozen dog semen
Khapra beetle measures: Upcoming changes to conditions for offshore treatments and certification(Important)
Effective from 9 April 2025
From 28 May 2025, the Department of Agriculture, Fisheries and Forestry (the department) will implement changes to our requirements for pre-border khapra beetle treatments and phytosanitary certification.
There will be three key changes:
1. Revis...
Related Cases:
Chickpeas for human consumption
|
Celery seed for human consumption
|
Coriander seed for human consumption
|
Non-Commodity Cargo Clearance
|
Cumin seed for human consumption
|
Bean seed for human consumption
|
Cucurbit seed for human consumption
|
Fennel seed for human consumption
|
Pelted wheat for human consumption
|
Raw seed for human consumption
|
Rice for human consumption or processing
|
Soybeans (excluding frozen) for human consumption
|
Split legumes for human consumption
|
Dried capsicum or chilli (whole, crushed or ground) for human consumption
|
Processed grain and seed products for human consumption
|
Whole dried peas for human consumption
|
Peanuts for human consumption or processing
|
Whole lentils for human consumption
|
Papaver somniferum seed for human consumption
|
Articles stuffed with dried herbs or seed
|
Dried herbs for human consumption
|
Dried apricot kernels
|
Dried herb products not for human consumption
|
Dried grapes for human consumption
|
Dried fruit
|
Sesame seed for human consumption
|
Dried vegetables for human consumption
|
Raw nuts for human consumption
|
Millet for human consumption
|
Tamarind for human consumption
|
Psyllium husks for human consumption
|
Dried dates or doum for human consumption
|
Dried and whole Ziziphus spp. for human consumption
|
Ground or whole peppercorns and pepper for human consumption
|
Processed banana for human consumption
Compliance-Based Intervention Scheme (CBIS) for multiple human therapeutics and medicines pathways(Important)
Effective from 7 April 2025
From 7 April 2025, the CBIS manages the biosecurity document assessment rate for the following import pathways at the time of importation:
• Human derived materials (excluding antibodies, cell lines and human milk)
• Human therapeutics and medicines ...
Related Cases:
Human therapeutics and medicines
Changes to the ‘Baits, lures, attractants and poisons for agricultural or domestic use’ BICON case(Important)
Effective from 4 April 2025
The Department of Agriculture, Fisheries and Forestry has made an administrative change to the 'Baits, lures, attractants and poisons for agricultural or domestic use' BICON case to include an option for 'Plant based, no listed as an approved ingredien...
Related Cases:
Baits, lures, attractants and poisons for agricultural or domestic use
Revised post-entry quarantine testing requirement for Actinidia spp. as budwood and tissue culture(Important)
Effective from 1 April 2025
The Department of Agriculture, Fisheries and Forestry has revised the post-entry quarantine (PEQ) requirements for Actinidia spp. imported as budwood and tissue culture for use as nursery stock. These revisions are being introduced based on a departmen...
Related Cases:
Actinidia spp. (kiwi fruit, gooseberry) for use as nursery stock
Reminder: New permit requirement for Brassicaceous and Cucurbitaceous seed for sowing from 1 July(Important)
Effective from 1 April 2025
Stakeholders are reminded that the new import permit requirement for Brassicaceous seed requiring treatment and Cucurbitaceous seed requiring testing and/or treatment, that are imported for an end use of sowing, will commence on 1 July 2025.
Informa...
Related Cases:
Brassicaceous seed for sowing requiring treatment
|
Cucurbita moschata seed for sowing
|
Lagenaria siceraria seed for sowing
|
Citrullus lanatus seed for sowing
|
Trichosanthes cucumerina seed for sowing
|
Cucumis melo seed for sowing
|
Cucurbita pepo seed for sowing
|
Cucumis sativus seed for sowing
|
Cucurbita maxima seed for sowing
Expansion of the CBIS onto multiple import pathways for human therapeutics and medicines(Important)
Effective from 28 March 2025
The department is expanding the onto multiple document-controlled commodity import pathways.
Expansion of CBIS eligible tariffs for Australian registered (AUST R) human therapeutics and medicines:
CBIS previously expanded to include AUST R human t...
Related Cases:
Human therapeutics and medicines